Co-CEOs Robert Duggan and Maky Zanganeh have each purchased 338,394 shares of Summit Therapeutics stock, with each transaction valued at $5,984,755.
https://www.tipranks.com/news/insider-trading/summit-therapeutics-co-ceos-make-bold-stock-purchases-insider-trading
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.